PMC:7195088 / 62577-62903 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7195088","sourcedb":"PMC","sourceid":"7195088","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7195088","text":"erature (21/21, 100%); (b) improved blood oxygenation (15/21, 71.4%); (c) normalization of lymphocyte count (10/17, 58.8%); (d) normalization of C-reactive protein (16/19, 82.4%); and (c) resolution of abnormalities on computed tomography (19/21, 90.5%). Interestingly, no adverse reactions were observed after tocilizumab adm","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"1859","span":{"begin":145,"end":163},"obj":"Gene"},{"id":"1870","span":{"begin":311,"end":322},"obj":"Chemical"}],"attributes":[{"id":"A1859","pred":"tao:has_database_id","subj":"1859","obj":"Gene:1401"},{"id":"A1870","pred":"tao:has_database_id","subj":"1870","obj":"MESH:C502936"},{"subj":"1859","pred":"source","obj":"LitCovid-PubTator"},{"subj":"1870","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T105","span":{"begin":36,"end":41},"obj":"Body_part"},{"id":"T106","span":{"begin":91,"end":101},"obj":"Body_part"},{"id":"T107","span":{"begin":156,"end":163},"obj":"Body_part"}],"attributes":[{"id":"A105","pred":"fma_id","subj":"T105","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A106","pred":"fma_id","subj":"T106","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A107","pred":"fma_id","subj":"T107","obj":"http://purl.org/sig/ont/fma/fma67257"},{"subj":"T105","pred":"source","obj":"LitCovid-PD-FMA-UBERON"},{"subj":"T106","pred":"source","obj":"LitCovid-PD-FMA-UBERON"},{"subj":"T107","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T50","span":{"begin":36,"end":41},"obj":"Body_part"}],"attributes":[{"id":"A50","pred":"uberon_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"subj":"T50","pred":"source","obj":"LitCovid-PD-UBERON"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T346","span":{"begin":24,"end":25},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T347","span":{"begin":36,"end":41},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T348","span":{"begin":36,"end":41},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"}],"attributes":[{"subj":"T346","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T347","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T348","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T88075","span":{"begin":156,"end":163},"obj":"Chemical"},{"id":"T73","span":{"begin":311,"end":322},"obj":"Chemical"}],"attributes":[{"id":"A65337","pred":"chebi_id","subj":"T88075","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A44828","pred":"chebi_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"subj":"T88075","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T73","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#bc93ec","default":true},{"id":"LitCovid-PD-FMA-UBERON","color":"#93eca2"},{"id":"LitCovid-PD-UBERON","color":"#ec939d"},{"id":"LitCovid-PD-CLO","color":"#93b7ec"},{"id":"LitCovid-PD-CHEBI","color":"#d1ec93"}]}]}}